Back
iShares Russell Top 200 Growth Index ETF Vs. Regeneron Pharmaceuticals, Inc. Industry Stock Comparison
Sell
49
IWY
iShares Russell Top 200 Growth Index ETF
Last Price:
$280.14
Seasonality Move:
2.84%
Buy
59
REGN
Regeneron Pharmaceuticals, Inc.
Last Price:
$785.06
Seasonality Move:
12.13%
Sell
49
iShares Russell Top 200 Growth Index ETF (IWY)
is a Sell
Is iShares Russell Top 200 Growth Index ETF a Buy, Sell or Hold?
-
The current iShares Russell Top 200 Growth Index ETF [IWY] share price is $278.12. The Score for IWY is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
IWY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
59
Regeneron Pharmaceuticals, Inc. (REGN)
is a Buy
Is Regeneron Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals, Inc. [REGN] share price is $785.17. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
REGN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IWY Stock Price Chart
What is iShares Russell Top 200 Growth Index ETF's stock price today?
-
The iShares Russell Top 200 Growth Index ETF share price today is $278.12Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IWY is experiencing slight buying pressure.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals, Inc.'s stock price today?
-
The Regeneron Pharmaceuticals, Inc. share price today is $785.17Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and REGN is experiencing slight buying pressure.
IWY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 53.28 | Buy |
| Chaikin Money Flow: | 76110 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (271.57 - 279.61) | Buy |
| Bollinger Bands (100): | (261.83 - 279.63) | Buy |
REGN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 190.52 | Buy |
| Relative Strength Index (14 RSI): | 67.85 | Buy |
| Chaikin Money Flow: | 31173 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (719.04 - 771.48) | Buy |
| Bollinger Bands (100): | (554.73 - 705.63) | Buy |
IWY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 275.1 | Buy |
| 20-day SMA: | 277.02 | Buy |
| 50-day SMA: | 277.09 | Buy |
| 200-day SMA: | 249 | Buy |
| 8-day EMA: | 275.78 | Buy |
| 20-day EMA: | 276.26 | Buy |
| 50-day EMA: | 271.04 | Buy |
| 200-day EMA: | 174.18 | Buy |
REGN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 758.91 | Buy |
| 20-day SMA: | 747.46 | Buy |
| 50-day SMA: | 686.87 | Buy |
| 200-day SMA: | 601.47 | Buy |
| 8-day EMA: | 551.68 | Buy |
| 20-day EMA: | 302.47 | Buy |
| 50-day EMA: | 139.05 | Buy |
| 200-day EMA: | 37.38 | Buy |
iShares Russell Top 200 Growth Index ETF Earnings Growth & IWY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Regeneron Pharmaceuticals, Inc. Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $3.81 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.74 per share, and an increase next year of $0.97 per share.
iShares Russell Top 200 Growth Index ETF Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Regeneron Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||